- cafead Oct 27, 2020 at 11:23: PM
via The pharma giant said Tuesday that COVID-19 would take a $2.5 billion bite out of its 2020 revenue, more than the $1.9 billion it had previously predicted. Growth in drugs that didn’t take a pandemic hit has softened that blow. In a quote-unquote normal year, though, Merck might be reporting sales growth of 8% to 10%, not the 1% it posted for Q3.
article source
article source